Bharat Biotech applies for COVID-19 vaccine trial in Bangladesh
Bharat Biotech has applied to conduct trials in Bangladesh for its COVID-19 vaccine, Covaxin, that was recently approved for emergency use in India. Mahmood-uz-Jahan, a director at the government-run Bangladesh Medical Research Council, said that the ethics committee will review the application. If granted approval, this would be the first trial of any COVID-19 vaccine in Bangladesh.